John W Winkelman
Massachusetts General Hospital · Massachusetts General Hospital (Partners Healthcare) · Sleep Health Centers, Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John W Winkelman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:12 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT04759703 · Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUDMassachusetts General Hospital · terminated · Sleep Disorder, Restless Legs Syndrome, Opioid-use Disorder · principal investigator
- Ph4NCT04706091 · Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic InsomniaMassachusetts General Hospital · completed · Restless Legs Syndrome, Insomnia, Sleep Disorder · principal investigator
- Ph4NCT03818581 · Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 DiabetesMassachusetts General Hospital · completed · Type 2 Diabetes Mellitus, Insomnia, Sleep Disorder · principal investigator
- Ph4NCT02138357 · Butrans for Treatment of Restless Legs SyndromeMassachusetts General Hospital · withdrawn · Restless Legs Syndrome · principal investigator
- N/ANCT01109537 · Altered Brain GABA and Glutamate in Restless Legs SyndromeBrigham and Women's Hospital · completed · Restless Legs Syndrome · principal investigator
- Early Ph1NCT00606411 · Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating DisorderMassachusetts General Hospital · completed · Sleep-Related Eating Disorder · principal investigator
- N/ANCT00555750 · Sleep Loss and Mechanisms of Impaired Glucose MetabolismBrigham and Women's Hospital · completed · Primary Insomnia · principal investigator
- Ph2NCT00247364 · A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)Sleep Health Centers · completed · Restless Legs Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Treatment of Restless Legs Symptoms with Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical TrialR21DA052861 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2021 to 2022 · $210,000 awarded in 2022Grant number is on one of their registry trials
- Cortical GABA in MDD and Primary Insomnia with Magnetic Resonance SpectroscopyR01MH095792 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2012 to 2016 · $426,060 awarded in 2016Same name and institution; not confirmed by an ID
- ESZOPICLONE TO COUNTERACT ADVERSE METABOLIC CONSEQUENCES OF PRIMARY INSOMNIAM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2007 to 2008 · $10,213 awarded in 2008Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:12 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- Comparison of pregabalin with pramipexole for restless legs syndrome.N Engl J Med · 2014165 citationsRCR 7.5
- Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).Sleep Med · 2004153 citationsRCR 5.3
- Efficacy and safety of pramipexole in restless legs syndrome.Neurology · 2006143 citationsRCR 4.8
- Antidepressants and periodic leg movements of sleep.Biol Psychiatry · 2005129 citationsRCR 4.5
- Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States.Mov Disord · 201091 citationsRCR 3.7
- Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate.Sleep Med · 200366 citationsRCR 2.0
- Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.Mov Disord · 201158 citationsRCR 2.4
- 54 citationsRCR 1.5
- Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.Neurology · 201639 citationsRCR 2.0
- 27 citationsRCR 5.4